Shopping Cart 0
Cart Subtotal
USD 0

Drugs of Abuse / Toxicology Rapid Tests - Medical Devices Pipeline Assessment, 2018

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 7500
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Drugs of Abuse / Toxicology Rapid Tests-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Drugs of Abuse / Toxicology Rapid Tests-Medical Devices Pipeline Assessment, 2018" provides an overview of Drugs of Abuse / Toxicology Rapid Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Drugs of Abuse / Toxicology Rapid Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Drugs of Abuse / Toxicology Rapid Tests under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Drugs of Abuse / Toxicology Rapid Tests and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Drugs of Abuse / Toxicology Rapid Tests under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Drugs of Abuse / Toxicology Rapid Tests Overview 6

3 Products under Development 7

3.1 Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Stage of Development 7

3.2 Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Territory 8

3.3 Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Regulatory Path 9

3.4 Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Estimated Approval Date 10

4 Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products under Development by Companies 11

4.1 Drugs of Abuse / Toxicology Rapid Tests Companies-Pipeline Products by Stage of Development 11

4.2 Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Stage of Development 12

5 Drugs of Abuse / Toxicology Rapid Tests Companies and Product Overview 13

5.1 American Bio Medica Corp Company Overview 13

5.1.1 American Bio Medica Corp Pipeline Products & Ongoing Clinical Trials Overview 13

5.2 Behavioral Diagnostics Inc Company Overview 17

5.2.1 Behavioral Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 17

5.3 Bio-Alternative Medical Devices Ltd Company Overview 18

5.3.1 Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 18

5.4 BioMedomics Inc Company Overview 19

5.4.1 BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 19

5.5 Biosensia Ltd Company Overview 21

5.5.1 Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview 21

5.6 Dimerix Ltd Company Overview 22

5.6.1 Dimerix Ltd Pipeline Products & Ongoing Clinical Trials Overview 22

5.7 Group K Diagnostics Company Overview 23

5.7.1 Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 23

5.8 ImmunoScience Inc Company Overview 26

5.8.1 ImmunoScience Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.9 Quidel Corp Company Overview 27

5.9.1 Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 27

5.10 Rapid Pathogen Screening Inc Company Overview 29

5.10.1 Rapid Pathogen Screening Inc Pipeline Products & Ongoing Clinical Trials Overview 29

5.11 Seacoast Science, Inc. Company Overview 30

5.11.1 Seacoast Science, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30

5.12 The University of South Australia Company Overview 31

5.12.1 The University of South Australia Pipeline Products & Ongoing Clinical Trials Overview 31

5.13 Thermo Fisher Scientific Inc Company Overview 32

5.13.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 32

5.14 True Diagnostics Inc Company Overview 33

5.14.1 True Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 33

6 Drugs of Abuse / Toxicology Rapid Tests- Recent Developments 34

6.1 May 14, 2018: ABMC Reports First Quarter 2018 Results 34

6.2 Apr 27, 2018: Dimerix: Quarterly Review-Q3 FY2018 34

6.3 Feb 28, 2018: ALFA receives another US FDA 510(k) clearance for Simple Cup multi-drug test with Driven Flow 36

6.4 Nov 14, 2017: ABMC Reports Third Quarter 2017 Results 37

6.5 Aug 16, 2017: FDA Grants OTC Clearance for ABMC's Rapid TOX CUP II 37

6.6 Aug 14, 2017: ABMC Reports Second Quarter 2017 Results 38

6.7 Jul 19, 2017: Alere Launches Alere iCup Rx Drug Screen For Detecting Commonly Misused And Abused Prescription Drugs 38

7 Appendix 40

7.1 Methodology 40

7.2 About GlobalData 43

7.3 Contact Us 43

7.4 Disclaimer 43


List Of Figure

1.2 List of Figures

Figure 1: Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Stage of Development 7

Figure 2: Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Territory 8

Figure 3: Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Regulatory Path 9

Figure 4: Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Estimated Approval Date 10


List Of Table

1.1 List of Tables

Table 1: Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Stage of Development 7

Table 2: Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Territory 8

Table 3: Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Regulatory Path 9

Table 4: Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Estimated Approval Date 10

Table 5: Drugs of Abuse / Toxicology Rapid Tests Companies-Pipeline Products by Stage of Development 11

Table 6: Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Stage of Development 12

Table 7: American Bio Medica Corp Pipeline Products & Ongoing Clinical Trials Overview 13

Table 8: Rapid Drug Screen-Nicotine-Product Status 13

Table 9: Rapid Drug Screen-Nicotine-Product Description 14

Table 10: Rapid ONE-Nicotine-Product Status 14

Table 11: Rapid ONE-Nicotine-Product Description 14

Table 12: Rapid TOX Cup II-CLIA-Product Status 15

Table 13: Rapid TOX Cup II-CLIA-Product Description 15

Table 14: Rapid TOX Cup II-Nicotine-Product Status 15

Table 15: Rapid TOX Cup II-Nicotine-Product Description 15

Table 16: RDS InCup-Nicotine-Product Status 16

Table 17: RDS InCup-Nicotine-Product Description 16

Table 18: Behavioral Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 17

Table 19: Epigenetic Alcohol Test-Product Status 17

Table 20: Epigenetic Alcohol Test-Product Description 17

Table 21: Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 18

Table 22: Digital Strip Reader-Drugs Of Abuse-Product Status 18

Table 23: Digital Strip Reader-Drugs Of Abuse-Product Description 18

Table 24: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 19

Table 25: Rapid Drug Overdose Test-Cocaine-Product Status 19

Table 26: Rapid Drug Overdose Test-Cocaine-Product Description 19

Table 27: Rapid Drug Overdose Test-Morphine-Product Status 20

Table 28: Rapid Drug Overdose Test-Morphine-Product Description 20

Table 29: Rapid Quantitative Acetaminophen Detection Assay-Product Status 20

Table 30: Rapid Quantitative Acetaminophen Detection Assay-Product Description 20

Table 31: Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview 21

Table 32: RapiPlex-Drugs Of Abuse Assay-Product Status 21

Table 33: RapiPlex-Drugs Of Abuse Assay-Product Description 21

Table 34: Dimerix Ltd Pipeline Products & Ongoing Clinical Trials Overview 22

Table 35: VisuaLine Multi Dip Panel-Product Status 22

Table 36: VisuaLine Multi Dip Panel-Product Description 22

Table 37: Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 23

Table 38: Multidiagnostic-Aflatoxin B1 Test-Product Status 23

Table 39: Multidiagnostic-Aflatoxin B1 Test-Product Description 23

Table 40: Multidiagnostic-Heavy Metals Test-Product Status 24

Table 41: Multidiagnostic-Heavy Metals Test-Product Description 24

Table 42: Multidiagnostic-Paraoxon Test-Product Status 24

Table 43: Multidiagnostic-Paraoxon Test-Product Description 25

Table 44: Multidiagnostic-Pentachlorophenol (PCP) Test-Product Status 25

Table 45: Multidiagnostic-Pentachlorophenol (PCP) Test-Product Description 25

Table 46: ImmunoScience Inc Pipeline Products & Ongoing Clinical Trials Overview 26

Table 47: Salivax-Drug Of Abuse-Product Status 26

Table 48: Salivax-Drug Of Abuse-Product Description 26

Table 49: Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 27

Table 50: Sofia-Toxicology Assay-Product Status 27

Table 51: Sofia-Toxicology Assay-Product Description 27

Table 52: Triage-Toxicology Assay-Product Status 28

Table 53: Triage-Toxicology Assay-Product Description 28

Table 54: Rapid Pathogen Screening Inc Pipeline Products & Ongoing Clinical Trials Overview 29

Table 55: OrganoTox-Product Status 29

Table 56: OrganoTox-Product Description 29

Table 57: Seacoast Science, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30

Table 58: Point-Of-Care Drug Screen Test-Product Status 30

Table 59: Point-Of-Care Drug Screen Test-Product Description 30

Table 60: The University of South Australia Pipeline Products & Ongoing Clinical Trials Overview 31

Table 61: Point-Of-Care Test-Drug Of Abuse-Product Status 31

Table 62: Point-Of-Care Test-Drug Of Abuse-Product Description 31

Table 63: Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 32

Table 64: Point-Of-Care Platform-Drugs Of Abuse Assay-Product Status 32

Table 65: Point-Of-Care Platform-Drugs Of Abuse Assay-Product Description 32

Table 66: True Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 33

Table 67: TrueDX-Drug Of Abuse Test-Product Status 33

Table 68: TrueDX-Drug Of Abuse Test-Product Description 33

Table 69: Glossary 42

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

American Bio Medica Corp, Rapid Drug Screen - Nicotine; American Bio Medica Corp, Rapid ONE - Nicotine; American Bio Medica Corp, Rapid TOX Cup II - CLIA; American Bio Medica Corp, Rapid TOX Cup II - Nicotine; American Bio Medica Corp, RDS InCup - Nicotine; Behavioral Diagnostics Inc, Epigenetic Alcohol Test; Bio-Alternative Medical Devices Ltd, Digital Strip Reader - Drugs Of Abuse; BioMedomics Inc, Rapid Drug Overdose Test - Cocaine; BioMedomics Inc, Rapid Drug Overdose Test - Morphine; BioMedomics Inc, Rapid Quantitative Acetaminophen Detection Assay; Biosensia Ltd, RapiPlex - Drugs Of Abuse Assay; Dimerix Ltd, VisuaLine Multi Dip Panel; Group K Diagnostics, Multidiagnostic - Aflatoxin B1 Test; Group K Diagnostics, Multidiagnostic - Heavy Metals Test; Group K Diagnostics, Multidiagnostic - Paraoxon Test; Group K Diagnostics, Multidiagnostic - Pentachlorophenol (PCP) Test; ImmunoScience Inc, Salivax - Drug Of Abuse; Quidel Corp, Sofia - Toxicology Assay; Quidel Corp, Triage - Toxicology Assay; Rapid Pathogen Screening Inc, OrganoTox; Seacoast Science, Inc., Point-Of-Care Drug Screen Test; The University of South Australia, Point-Of-Care Test - Drug Of Abuse; Thermo Fisher Scientific Inc, Point-Of-Care Platform - Drugs Of Abuse Assay; True Diagnostics Inc, TrueDX - Drug Of Abuse Test


Companies

American Bio Medica Corp

Behavioral Diagnostics Inc

Bio-Alternative Medical Devices Ltd

BioMedomics Inc

Biosensia Ltd

Dimerix Ltd

Group K Diagnostics

ImmunoScience Inc

Quidel Corp

Rapid Pathogen Screening Inc

Seacoast Science, Inc.

The University of South Australia

Thermo Fisher Scientific Inc

True Diagnostics Inc

Drugs of Abuse / Toxicology Rapid Tests-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Drugs of Abuse / Toxicology Rapid Tests-Medical Devices Pipeline Assessment, 2018" provides an overview of Drugs of Abuse / Toxicology Rapid Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Drugs of Abuse / Toxicology Rapid Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Drugs of Abuse / Toxicology Rapid Tests under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Drugs of Abuse / Toxicology Rapid Tests and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Drugs of Abuse / Toxicology Rapid Tests under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.

READ MORE

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Drugs of Abuse / Toxicology Rapid Tests Overview 6

3 Products under Development 7

3.1 Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Stage of Development 7

3.2 Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Territory 8

3.3 Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Regulatory Path 9

3.4 Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Estimated Approval Date 10

4 Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products under Development by Companies 11

4.1 Drugs of Abuse / Toxicology Rapid Tests Companies-Pipeline Products by Stage of Development 11

4.2 Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Stage of Development 12

5 Drugs of Abuse / Toxicology Rapid Tests Companies and Product Overview 13

5.1 American Bio Medica Corp Company Overview 13

5.1.1 American Bio Medica Corp Pipeline Products & Ongoing Clinical Trials Overview 13

5.2 Behavioral Diagnostics Inc Company Overview 17

5.2.1 Behavioral Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 17

5.3 Bio-Alternative Medical Devices Ltd Company Overview 18

5.3.1 Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 18

5.4 BioMedomics Inc Company Overview 19

5.4.1 BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 19

5.5 Biosensia Ltd Company Overview 21

5.5.1 Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview 21

5.6 Dimerix Ltd Company Overview 22

5.6.1 Dimerix Ltd Pipeline Products & Ongoing Clinical Trials Overview 22

5.7 Group K Diagnostics Company Overview 23

5.7.1 Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 23

5.8 ImmunoScience Inc Company Overview 26

5.8.1 ImmunoScience Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.9 Quidel Corp Company Overview 27

5.9.1 Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 27

5.10 Rapid Pathogen Screening Inc Company Overview 29

5.10.1 Rapid Pathogen Screening Inc Pipeline Products & Ongoing Clinical Trials Overview 29

5.11 Seacoast Science, Inc. Company Overview 30

5.11.1 Seacoast Science, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30

5.12 The University of South Australia Company Overview 31

5.12.1 The University of South Australia Pipeline Products & Ongoing Clinical Trials Overview 31

5.13 Thermo Fisher Scientific Inc Company Overview 32

5.13.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 32

5.14 True Diagnostics Inc Company Overview 33

5.14.1 True Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 33

6 Drugs of Abuse / Toxicology Rapid Tests- Recent Developments 34

6.1 May 14, 2018: ABMC Reports First Quarter 2018 Results 34

6.2 Apr 27, 2018: Dimerix: Quarterly Review-Q3 FY2018 34

6.3 Feb 28, 2018: ALFA receives another US FDA 510(k) clearance for Simple Cup multi-drug test with Driven Flow 36

6.4 Nov 14, 2017: ABMC Reports Third Quarter 2017 Results 37

6.5 Aug 16, 2017: FDA Grants OTC Clearance for ABMC's Rapid TOX CUP II 37

6.6 Aug 14, 2017: ABMC Reports Second Quarter 2017 Results 38

6.7 Jul 19, 2017: Alere Launches Alere iCup Rx Drug Screen For Detecting Commonly Misused And Abused Prescription Drugs 38

7 Appendix 40

7.1 Methodology 40

7.2 About GlobalData 43

7.3 Contact Us 43

7.4 Disclaimer 43


List Of Figure

1.2 List of Figures

Figure 1: Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Stage of Development 7

Figure 2: Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Territory 8

Figure 3: Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Regulatory Path 9

Figure 4: Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Estimated Approval Date 10


List Of Table

1.1 List of Tables

Table 1: Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Stage of Development 7

Table 2: Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Territory 8

Table 3: Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Regulatory Path 9

Table 4: Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Estimated Approval Date 10

Table 5: Drugs of Abuse / Toxicology Rapid Tests Companies-Pipeline Products by Stage of Development 11

Table 6: Drugs of Abuse / Toxicology Rapid Tests-Pipeline Products by Stage of Development 12

Table 7: American Bio Medica Corp Pipeline Products & Ongoing Clinical Trials Overview 13

Table 8: Rapid Drug Screen-Nicotine-Product Status 13

Table 9: Rapid Drug Screen-Nicotine-Product Description 14

Table 10: Rapid ONE-Nicotine-Product Status 14

Table 11: Rapid ONE-Nicotine-Product Description 14

Table 12: Rapid TOX Cup II-CLIA-Product Status 15

Table 13: Rapid TOX Cup II-CLIA-Product Description 15

Table 14: Rapid TOX Cup II-Nicotine-Product Status 15

Table 15: Rapid TOX Cup II-Nicotine-Product Description 15

Table 16: RDS InCup-Nicotine-Product Status 16

Table 17: RDS InCup-Nicotine-Product Description 16

Table 18: Behavioral Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 17

Table 19: Epigenetic Alcohol Test-Product Status 17

Table 20: Epigenetic Alcohol Test-Product Description 17

Table 21: Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 18

Table 22: Digital Strip Reader-Drugs Of Abuse-Product Status 18

Table 23: Digital Strip Reader-Drugs Of Abuse-Product Description 18

Table 24: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 19

Table 25: Rapid Drug Overdose Test-Cocaine-Product Status 19

Table 26: Rapid Drug Overdose Test-Cocaine-Product Description 19

Table 27: Rapid Drug Overdose Test-Morphine-Product Status 20

Table 28: Rapid Drug Overdose Test-Morphine-Product Description 20

Table 29: Rapid Quantitative Acetaminophen Detection Assay-Product Status 20

Table 30: Rapid Quantitative Acetaminophen Detection Assay-Product Description 20

Table 31: Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview 21

Table 32: RapiPlex-Drugs Of Abuse Assay-Product Status 21

Table 33: RapiPlex-Drugs Of Abuse Assay-Product Description 21

Table 34: Dimerix Ltd Pipeline Products & Ongoing Clinical Trials Overview 22

Table 35: VisuaLine Multi Dip Panel-Product Status 22

Table 36: VisuaLine Multi Dip Panel-Product Description 22

Table 37: Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 23

Table 38: Multidiagnostic-Aflatoxin B1 Test-Product Status 23

Table 39: Multidiagnostic-Aflatoxin B1 Test-Product Description 23

Table 40: Multidiagnostic-Heavy Metals Test-Product Status 24

Table 41: Multidiagnostic-Heavy Metals Test-Product Description 24

Table 42: Multidiagnostic-Paraoxon Test-Product Status 24

Table 43: Multidiagnostic-Paraoxon Test-Product Description 25

Table 44: Multidiagnostic-Pentachlorophenol (PCP) Test-Product Status 25

Table 45: Multidiagnostic-Pentachlorophenol (PCP) Test-Product Description 25

Table 46: ImmunoScience Inc Pipeline Products & Ongoing Clinical Trials Overview 26

Table 47: Salivax-Drug Of Abuse-Product Status 26

Table 48: Salivax-Drug Of Abuse-Product Description 26

Table 49: Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 27

Table 50: Sofia-Toxicology Assay-Product Status 27

Table 51: Sofia-Toxicology Assay-Product Description 27

Table 52: Triage-Toxicology Assay-Product Status 28

Table 53: Triage-Toxicology Assay-Product Description 28

Table 54: Rapid Pathogen Screening Inc Pipeline Products & Ongoing Clinical Trials Overview 29

Table 55: OrganoTox-Product Status 29

Table 56: OrganoTox-Product Description 29

Table 57: Seacoast Science, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30

Table 58: Point-Of-Care Drug Screen Test-Product Status 30

Table 59: Point-Of-Care Drug Screen Test-Product Description 30

Table 60: The University of South Australia Pipeline Products & Ongoing Clinical Trials Overview 31

Table 61: Point-Of-Care Test-Drug Of Abuse-Product Status 31

Table 62: Point-Of-Care Test-Drug Of Abuse-Product Description 31

Table 63: Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 32

Table 64: Point-Of-Care Platform-Drugs Of Abuse Assay-Product Status 32

Table 65: Point-Of-Care Platform-Drugs Of Abuse Assay-Product Description 32

Table 66: True Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 33

Table 67: TrueDX-Drug Of Abuse Test-Product Status 33

Table 68: TrueDX-Drug Of Abuse Test-Product Description 33

Table 69: Glossary 42

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

American Bio Medica Corp, Rapid Drug Screen - Nicotine; American Bio Medica Corp, Rapid ONE - Nicotine; American Bio Medica Corp, Rapid TOX Cup II - CLIA; American Bio Medica Corp, Rapid TOX Cup II - Nicotine; American Bio Medica Corp, RDS InCup - Nicotine; Behavioral Diagnostics Inc, Epigenetic Alcohol Test; Bio-Alternative Medical Devices Ltd, Digital Strip Reader - Drugs Of Abuse; BioMedomics Inc, Rapid Drug Overdose Test - Cocaine; BioMedomics Inc, Rapid Drug Overdose Test - Morphine; BioMedomics Inc, Rapid Quantitative Acetaminophen Detection Assay; Biosensia Ltd, RapiPlex - Drugs Of Abuse Assay; Dimerix Ltd, VisuaLine Multi Dip Panel; Group K Diagnostics, Multidiagnostic - Aflatoxin B1 Test; Group K Diagnostics, Multidiagnostic - Heavy Metals Test; Group K Diagnostics, Multidiagnostic - Paraoxon Test; Group K Diagnostics, Multidiagnostic - Pentachlorophenol (PCP) Test; ImmunoScience Inc, Salivax - Drug Of Abuse; Quidel Corp, Sofia - Toxicology Assay; Quidel Corp, Triage - Toxicology Assay; Rapid Pathogen Screening Inc, OrganoTox; Seacoast Science, Inc., Point-Of-Care Drug Screen Test; The University of South Australia, Point-Of-Care Test - Drug Of Abuse; Thermo Fisher Scientific Inc, Point-Of-Care Platform - Drugs Of Abuse Assay; True Diagnostics Inc, TrueDX - Drug Of Abuse Test


Companies

American Bio Medica Corp

Behavioral Diagnostics Inc

Bio-Alternative Medical Devices Ltd

BioMedomics Inc

Biosensia Ltd

Dimerix Ltd

Group K Diagnostics

ImmunoScience Inc

Quidel Corp

Rapid Pathogen Screening Inc

Seacoast Science, Inc.

The University of South Australia

Thermo Fisher Scientific Inc

True Diagnostics Inc